-
1
-
-
0034791598
-
The spectrum of liver disease in the general population: Lesson from the Dionysos study
-
Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001; 35:531-7.
-
(2001)
J Hepatol
, vol.35
, pp. 531-537
-
-
Bellentani, S.1
Tiribelli, C.2
-
2
-
-
0036828783
-
Course and outcome of hepatitis C
-
Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36 (5 suppl 1): S21-9.
-
(2002)
Hepatology
, vol.36
, Issue.5 SUPPL. 1
-
-
Hoofnagle, J.H.1
-
3
-
-
0025766427
-
The interferons. Mechanisms of action and clinical applications
-
Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991; 266:1375-83.
-
(1991)
JAMA
, vol.266
, pp. 1375-1383
-
-
Baron, S.1
Tyring, S.K.2
Fleischmann Jr, W.R.3
Coppenhaver, D.H.4
Niesel, D.W.5
Klimpel, G.R.6
-
5
-
-
0030886005
-
Side-effects of alpha interferon in chronic hepatitis C
-
Dusheiko G. Side-effects of alpha interferon in chronic hepatitis C. Hepatology 1997; 26 (3 suppl 1): 112S-121S.
-
(1997)
Hepatology
, vol.26
, Issue.3 SUPPL. 1
-
-
Dusheiko, G.1
-
7
-
-
0030279780
-
Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha
-
Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, et al. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996; 101:482-7.
-
(1996)
Am J Med
, vol.101
, pp. 482-487
-
-
Roti, E.1
Minelli, R.2
Giuberti, T.3
Marchelli, S.4
Schianchi, C.5
Gardini, E.6
-
8
-
-
0031921572
-
Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients
-
Floreani A, Chiaramonte M, Greggio NA, Fabris P, De Lazzari F, Naccarato R, et al. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients. Ital J Gastroenterol Hepatol 1998; 30:71-6.
-
(1998)
Ital J Gastroenterol Hepatol
, vol.30
, pp. 71-76
-
-
Floreani, A.1
Chiaramonte, M.2
Greggio, N.A.3
Fabris, P.4
De Lazzari, F.5
Naccarato, R.6
-
9
-
-
0032999613
-
HLA antigens in patients with interferon-alpha induced autoimmune thyroid disorders in chronic hepatitis C
-
Kakizaki S, Takagi H, Murakami M, Takayama H, Mori M. HLA antigens in patients with interferon-alpha induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol 1999; 30: 794-800.
-
(1999)
J Hepatol
, vol.30
, pp. 794-800
-
-
Kakizaki, S.1
Takagi, H.2
Murakami, M.3
Takayama, H.4
Mori, M.5
-
10
-
-
0023680697
-
An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer
-
Fentiman IS, Balkwill FR, Thomas BS, Russell MJ, Todd I, Bottazzo GF. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 1988; 24:1299-303.
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 1299-1303
-
-
Fentiman, I.S.1
Balkwill, F.R.2
Thomas, B.S.3
Russell, M.J.4
Todd, I.5
Bottazzo, G.F.6
-
11
-
-
0036498601
-
A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms non-destructive to destructive thyroiditis in experimental autoimmune thyroiditis
-
Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms non-destructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 2002; 168: 2470-4.
-
(2002)
J Immunol
, vol.168
, pp. 2470-2474
-
-
Wang, S.H.1
Bretz, J.D.2
Phelps, E.3
Mezosi, E.4
Arscott, P.L.5
Utsugi, S.6
-
12
-
-
0031465313
-
Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature
-
Koh LK, Greenspan FS, Yeo PP. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997; 7:891-6.
-
(1997)
Thyroid
, vol.7
, pp. 891-896
-
-
Koh, L.K.1
Greenspan, F.S.2
Yeo, P.P.3
-
13
-
-
0038168312
-
Interferon-alpha and autoimmune thyroid disease
-
Prummel MF, Laurberg P. Interferon-alpha and autoimmune thyroid disease. Thyroid 2003; 13: 547-51.
-
(2003)
Thyroid
, vol.13
, pp. 547-551
-
-
Prummel, M.F.1
Laurberg, P.2
-
14
-
-
0032527967
-
Increased risk of autoimmune thyroid disease in hepatitis C vs. hepatitis B before, during, and after discontinuing interferon therapy
-
Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs. hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158: 1445-8.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1445-1448
-
-
Fernandez-Soto, L.1
Gonzalez, A.2
Escobar-Jimenez, F.3
Vazquez, R.4
Ocete, E.5
Olea, N.6
-
15
-
-
0034119793
-
Virologic factors related to interferon-alpha induced thyroid dysfunction in patients with chronic hepatitis C
-
Hsieh MC, Yu ML, Chuang WL, Shin SJ, Dai CY, Chen SC, et al. Virologic factors related to interferon-alpha induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 2000; 142:431-7.
-
(2000)
Eur J Endocrinol
, vol.142
, pp. 431-437
-
-
Hsieh, M.C.1
Yu, M.L.2
Chuang, W.L.3
Shin, S.J.4
Dai, C.Y.5
Chen, S.C.6
-
16
-
-
0028266831
-
The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C
-
Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89:399-403.
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 399-403
-
-
Watanabe, U.1
Hashimoto, E.2
Hisamitsu, T.3
Obata, H.4
Hayashi, N.5
-
17
-
-
0036091858
-
Thyroid dysfunction during treatment of chronic hepatitis C with interferon-alpha: No association with either interferon dosage or efficacy of therapy
-
Dalgard O, Bjoro K, Hellum K, Myrvang B, Bjoro T, Haug E, et al. Thyroid dysfunction during treatment of chronic hepatitis C with interferon-alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med 2002; 251:400-6.
-
(2002)
J Intern Med
, vol.251
, pp. 400-406
-
-
Dalgard, O.1
Bjoro, K.2
Hellum, K.3
Myrvang, B.4
Bjoro, T.5
Haug, E.6
-
18
-
-
0032055507
-
Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
-
Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998; 160:3487-93.
-
(1998)
J Immunol
, vol.160
, pp. 3487-3493
-
-
Ning, Q.1
Brown, D.2
Parodo, J.3
Cattral, M.4
Gorczynski, R.5
Cole, E.6
-
19
-
-
0031663638
-
The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses
-
Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998; 79 (pt 10):2381-91.
-
(1998)
J Gen Virol
, vol.79
, Issue.PART 10
, pp. 2381-2391
-
-
Hultgren, C.1
Milich, D.R.2
Weiland, O.3
Sallberg, M.4
-
20
-
-
0036299570
-
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism
-
Carella C, Mazziotti G, Morisco F, Rotondi M, Cioffi M, Tuccillo C, et al. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol 2002; 146:743-9.
-
(2002)
Eur J Endocrinol
, vol.146
, pp. 743-749
-
-
Carella, C.1
Mazziotti, G.2
Morisco, F.3
Rotondi, M.4
Cioffi, M.5
Tuccillo, C.6
-
21
-
-
0030927636
-
Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon-alpha therapy
-
Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon-alpha therapy. Hepatology 1997; 26: 206-10.
-
(1997)
Hepatology
, vol.26
, pp. 206-210
-
-
Deutsch, M.1
Dourakis, S.2
Manesis, E.K.3
Gioustozi, A.4
Hess, G.5
Horsch, A.6
-
22
-
-
0026604957
-
Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha
-
Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 1992; 102: 2155-60.
-
(1992)
Gastroenterology
, vol.102
, pp. 2155-2160
-
-
Lisker-Melman, M.1
Di Bisceglie, A.M.2
Usala, S.J.3
Weintraub, B.4
Murray, L.M.5
Hoofnagle, J.H.6
-
23
-
-
0031465313
-
Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature
-
Koh LK, Greenspan FS, Yeo PP. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997; 7: 891-6.
-
(1997)
Thyroid
, vol.7
, pp. 891-896
-
-
Koh, L.K.1
Greenspan, F.S.2
Yeo, P.P.3
-
25
-
-
33645291491
-
Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis
-
Kee KM, Lee CM, Wang JH, Tung HD, Changchien CS, Lu SN, et al. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. J Gastroenterol Hepatol 2006; 21 (1 pt 2): 319-26.
-
(2006)
J Gastroenterol Hepatol
, vol.21
, Issue.1 PART 2
, pp. 319-326
-
-
Kee, K.M.1
Lee, C.M.2
Wang, J.H.3
Tung, H.D.4
Changchien, C.S.5
Lu, S.N.6
-
26
-
-
4043145015
-
Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha
-
Foldes I, David K, Horvath G, Osztrogonacz H, Jankovics K, Tolvaj G. Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha. Orv Hetil 2004; 145:1211-6.
-
(2004)
Orv Hetil
, vol.145
, pp. 1211-1216
-
-
Foldes, I.1
David, K.2
Horvath, G.3
Osztrogonacz, H.4
Jankovics, K.5
Tolvaj, G.6
-
27
-
-
8844247779
-
Incidence of thyroid dysfunction during interferon-alpha-2b and ribavirin therapy in men with chronic hepatitis C: A prospective cohort study
-
Bini EJ, Mehandru S. Incidence of thyroid dysfunction during interferon-alpha-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study. Arch Intern Med 2004; 164: 2371-6.
-
(2004)
Arch Intern Med
, vol.164
, pp. 2371-2376
-
-
Bini, E.J.1
Mehandru, S.2
-
28
-
-
27644595245
-
The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha-2beta and Ribavirin
-
Oct 12;
-
Tran HA, Jones TL, Batey RG. The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha-2beta and Ribavirin. BMC Endocr Disord 2005 Oct 12; 5: 8.
-
(2005)
BMC Endocr Disord
, vol.5
, pp. 8
-
-
Tran, H.A.1
Jones, T.L.2
Batey, R.G.3
-
29
-
-
0034641085
-
American Thyroid Association guidelines for detection of thyroid dysfunction
-
Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigus ST, Levy EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160:1573-5.
-
(2000)
Arch Intern Med
, vol.160
, pp. 1573-1575
-
-
Ladenson, P.W.1
Singer, P.A.2
Ain, K.B.3
Bagchi, N.4
Bigus, S.T.5
Levy, E.G.6
-
30
-
-
0034571359
-
Thyroid disease in HCV carriers undergoing antivirai therapy with interferon plus ribavirin
-
Parana R, Cruz M, Santos-Jesus R, Ferreira K, Codes L, Cruz T. Thyroid disease in HCV carriers undergoing antivirai therapy with interferon plus ribavirin. Braz J Infect Dis 2000; 4: 284-90.
-
(2000)
Braz J Infect Dis
, vol.4
, pp. 284-290
-
-
Parana, R.1
Cruz, M.2
Santos-Jesus, R.3
Ferreira, K.4
Codes, L.5
Cruz, T.6
-
31
-
-
0034846855
-
Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: Screening and monitoring recommendations
-
Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract 2001; 7: 52-8.
-
(2001)
Endocr Pract
, vol.7
, pp. 52-58
-
-
Ward, D.L.1
Bing-You, R.G.2
|